1887

Journal of General Virology header logo

Volume 80, Issue 2

Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b Free

Abstract

Hypervariable region 1 (HVR1) sequences of 96 clones at six time-points representing 27 variants in two major and one minor group were identified in a patient with chronic hepatitis C virus (HCV) infection over 3 years. Major and selected minor variants were used to design synthetic peptides corresponding to the HVR1 C terminus. Peptide ELISA reactivity with IgG was plotted against the corresponding clone frequency, and three patterns emerged: (1) three peptides were unreactive; (2) antibodies against two peptides followed emergence of the corresponding variant, suggesting isolate-specificity; (3) antibodies against four peptides preceded the appearance of the corresponding variant, indicating cross-reactivity or previous exposure. Cross-reactivity was investigated further: sera from six time-points were tested against 11 unrelated HVR1 peptides, seven of which (63.6%) showed cross-reactivity at all time-points. Cross-reactivity of nine patient-specific peptides tested against a panel of 45 heterologous sera from chronic HCV carriers ranged between 0 and 20%. Only three of 27 variants appeared at more than one time-point and in two cases specific and/or cross-reactive HVR1 antibodies coexisted with the corresponding variant, consistent with emergence of escape mutants. In addition, analysis of HVR1 IgG reactivity within a group of closely related patient-specific peptides revealed a loss of reactivity in one peptide attributable to a single amino acid substitution. Interferon-alpha treatment considerably reduced viral RNA but, paradoxically, heterogeneity increased.

  • Received:
  • Accepted:
  • Published Online:
© Journal of General Virology 1999
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-2-317
1999-02-01
2024-04-25
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/2/0800317a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-2-317&mimeType=html&fmt=ahah

References

  1. Allander T., Beyene A., Jacobson S. H., Grillner L., Persson M. A. A. 1997; Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response. Journal of Infectious Diseases 175:26–31
     [Google Scholar]
  2. Bukh J., Purcell R., Miller R. 1993; At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide. Proceedings of the National Academy of Sciences, USA 90:8234–8238
     [Google Scholar]
  3. Colombo M., Rumi M. G., Donato M. F., Tomassini M. A., Del Ninno E., Ronchi G., Kuo G., Houghton M. 1991; Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma. Digestive Diseases and Sciences 36:1130–1133
     [Google Scholar]
  4. DiBisceglie A. M., Goodman Z. D., Ishak K. G., Hoofnagle J. H., Melpolder J. J., Alter H. J. 1991; Long-term clinical and histo-pathological follow-up of chronic posttransfusion hepatitis. Hepatology 14:969–974
     [Google Scholar]
  5. Di Marzo Veronese F., Reitz M. S. Jr, Gupta G., Robert-Gouroff M., Boyer-Thompson C., Louie A., Gallo R. C., Lusso P. 1993; Loss of a neutralizing epitope by a spontaneous point mutation in the V3 loop of HIV-1 isolated from an infected laboratory worker. Journal of Biological Chemistry 268:25894–25901
     [Google Scholar]
  6. Enomoto N., Kurosaki M., Tanaka Y., Marumo F., Sato C. 1994; Fluctuation of hepatitis C virus quasispecies in persistent infection and interferon treatment revealed by single-strand conformation polymorphism analysis. Journal of General Virology 75:1361–1369
     [Google Scholar]
  7. Enomoto N., Sakuma I., Asahina Y., Kurosaki M., Murakami T., Yamamoto C., Izumi N., Marumo F., Sato C. 1995; Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b: sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. Journal of Clinical Investigations 96:224–230
     [Google Scholar]
  8. Farci P., Shimoda A., Wong D., Cabezon T., De Gioannis D., Strazzera A., Shimizu Y., Shapiro M., Alter H. J., Purcell R. H. 1996; Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proceedings of the National Academy of Sciences, USA 93:15394–15399
     [Google Scholar]
  9. Felsenstein J. 1989; PHYLIP: Phylogeny inference package (version 3.2). Cladistics 5:164–166
     [Google Scholar]
  10. Gale M. J. Jr, Korth M. J., Tang N. M., Tan S.-L., Hopkins D. A., Dever T. E., Polyak S. J., Gretch D. R., Katze M. G. 1997; Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein. Virology 230:217–227
     [Google Scholar]
  11. Higashi Y., Kakumu S., Yoshioka K., Wakita T., Mizokami M., Ohba K., Ito Y., Ishikawa T., Takayanagi M., Nagai Y. 1993; Dynamics of genome change in the E2/NS1 region of hepatitis C virus in vivo. Virology 197:659–668
     [Google Scholar]
  12. Hohne M., Schrier E., Roggendorf M. 1994; Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak. Archives of Virology 137:25–34
     [Google Scholar]
  13. Honda M., Kaneko S., Sakai A., Unoura M., Murakami S., Kobayashi K. 1994; Degree of diversity of hepatitis C virus quasispecies and progression of liver disease. Hepatology 20:1144–1151
     [Google Scholar]
  14. Jackson P., Petrik J., Alexander G. J. M., Pearson G., Allain J.-P. 1997; Reactivity of synthetic peptides representing selected sections of hepatitis C virus core and envelope proteins with a panel of hepatitis C virus-seropositive human plasma. Journal of Medical Virology 51:67–79
     [Google Scholar]
  15. Kato N., Sekiya H., Ootsuyama Y., Nakazawa T., Hijikata M., Ohkoshi S., Shimotohno K. 1993; Humoral immune response to hypervariable region 1 of the putative envelope glycoprotein (gp 70) of the hepatitis C virus. Journal of Virology 67:3923–3930
     [Google Scholar]
  16. Kato N., Ootsuyama Y., Sekiya H., Ohkoshi S., Nakazawa T., Hijikata M., Shimotohno K. 1994; Genetic drift in hypervariable region 1 of the viral genome in persistent hepatitis C virus infection. Journal of Virology 68:4776–4784
     [Google Scholar]
  17. Kumar U., Monjardino J., Thomas H. C. 1994; Hypervariable region of hepatitis C virus envelope glycoprotein (E2 NS1) in an agammaglobulinemic patient. Gastroenterology 106:1072–1075
     [Google Scholar]
  18. Kurosaki M., Enomoto N., Marumo F., Sato C. 1993; Rapid sequence variation of the hypervariable region of hepatitis C virus during the course of chronic hepatitis. Hepatology 18:1293–1299
     [Google Scholar]
  19. Lawal Z., Petrik J., Wong V.-S., Alexander G. J. M., Allain J.-P. 1997; Hepatitis C virus genomic variability in untreated and immunosuppressed patients. Virology 228:107–111
     [Google Scholar]
  20. Lesniewski R. R., Boardway K. M., Casey J. M., Desai S. M., Devare S. G., Leung T. K., Mushawar I. K. 1993; Hypervariable 5′-terminus of hepatitis C virus E2/NS1 encodes antigenically distinct variants. Journal of Medical Virology 40:150–156
     [Google Scholar]
  21. Manzin A., Solforosi L., Petrelli E., Maccari G., Tosone G., Piazza M., Clementi M. 1998; Evolution of hypervariable region 1 of hepatitis C virus in primary infection. Journal of Virology 72:6271–6276
     [Google Scholar]
  22. Martell M., Esteban J. I., Quer J., Genesca J., Weiner A., Esteban R., Guardia J., Gomez J. 1992; Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. Journal of Virology 66:3225–3229
     [Google Scholar]
  23. Martell M., Esteban J. I., Quer J., Vargas V., Esteban R., Guardia J., Gomez J. 1994; Dynamic behaviour ofhepatitis C virus quasispecies in patients undergoing orthotopic liver transplantation. Journal of Virology 68:3425–3436
     [Google Scholar]
  24. Naito M., Hayashi N., Moribe T., Hagiwara H., Mita E., Kanazawa Y., Kasahara A., Fusamoto H., Kamada T. 1995; Hepatitis C viral quasispecies in hepatitis C virus carriers with normal liver enzymes and patients with type C chronic liver disease. Hepatology 22:407–412
     [Google Scholar]
  25. Nakamoto Y., Kaneko S., Ohno H., Honda M., Unoura M., Murakami S., Kobayashi K. 1996; B-cell epitopes in hypervariable region 1 of hepatitis C virus obtained from patients with chronic persistent hepatitis. Journal of Medical Virology 50:35–41
     [Google Scholar]
  26. Nakazawa T., Kato N., Ootsuyama Y., Sekiya H., Fujioka T., Shibuya A., Shimotohno K. 1994; Genetic alteration ofthe hepatitis C virus hypervariable region obtained from an asymptomatic carrier. International Journal of Cancer 56:204–207
     [Google Scholar]
  27. Okada S. I., Akahane H., Suzuki M., Okamoto H., Mishiro S. 1992; The degree of variability in the aminoterminal region of the E2/NS1 protein of hepatitis C virus correlates with responsiveness to interferon therapy in viremic patients. Hepatology 16:619–624
     [Google Scholar]
  28. Petrik J., Pearson G. M. J., Allain J.-P. 1997; High throughput PCR detection of HCV based on semiautomated multisample RNA capture. Journal of Virological Methods 64:147–159
     [Google Scholar]
  29. Polyak S. J., McArdle S., Liu S.-L., Sullivan D. G., Chung M., Hofgartner W. T., Carithers R. L., McMahon B. J., Mullins J. I., Corey L., Gretch D. R. 1998; Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivitydetermining region during interferon therapy and natural infection. Journal of Virology 72:4288–4296
     [Google Scholar]
  30. Rosa D., Campagnoli S., Moretto C., Guenzi E., Cousens L., Chin M., Dong C., Weiner A., Lau J. Y. N., Choo Q.-L., Chien D., Pileri P., Houghton M., Abrignani S. 1996; A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorometric assessment of envelope glycoprotein 2 binding to target cells. Proceedings ofthe National Academy of Sciences, USA 93:1759–1763
     [Google Scholar]
  31. Sakamoto N., Enomoto N., Kurosaki M., Marumo F., Sato C. 1994; Sequential change of the hypervariable region of the hepatitis C virus genome in acute infection. Journal ofMedical Virology 42:103–108
     [Google Scholar]
  32. Scarcelli E., Cerino A., Esposito G., Silini E., Mondelli M. U., Traboni C. 1995; Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp 70) hypervariable region 1 in viremic hepatitis C virus-infected patients. Journal of Virology 60:4407–4412
     [Google Scholar]
  33. Shimizu Y. K., Hijikata M., Wamoto A., Alter H. J., Purcell R. H., Yoshikura H. 1994; Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. Journal of Virology 68:1494–1500
     [Google Scholar]
  34. Shimizu Y. K., Igarashi H., Kiyohara T., Cabezon T., Farci P., Purcell R. H., Yoshikura H. 1996; A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures. Virology 223:409–412
     [Google Scholar]
  35. Shindo M., Hamada K., Koya S., Arai K., Sokawa Y., Okuno T. 1996; The clinical significance of changes in genetic heterogeneity of the hypervariable region 1 in chronic hepatitis C with interferon therapy. Hepatology 24:1018–1023
     [Google Scholar]
  36. Simmonds P., Holmes E. C., Cha T.-A., Chan S.-W., McOmish F., Irvine B., Beall E., Yap P. L., Kolberg J., Urdea M. S. 1993; Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. Journal of General Virology 74:2391–2399
     [Google Scholar]
  37. Sugiyama K., Kato N., Mizutani T., Ikeda M., Tanaka T., Shimotohno K. 1997; Genetic analysis of the hepatitis C virus (HCV) genome from HCV-infected human T cells. Journal ofGeneral Virology 78:329–336
     [Google Scholar]
  38. Swofford D. L. 1991; PAUP: Phylogenetic analysis using parsimony (version 3.1). Distributed by the Illinois Natural History Survey Champaign, Illinois, USA:
     [Google Scholar]
  39. Taniguchi S., Okamoto H., Sakamoto M., Kojima M., Tsuda F., Tanaka T., Munekata E., Muchmore E. E., Peterson D. A., Mishiro S. 1993; A structurally flexible and antigenically variable N-terminal domain of the hepatitis C virus E2/NS1 protein: implication for an escape from antibody. Virology 195:297–301
     [Google Scholar]
  40. van Doorn L.-J., Quint W., Tsiquaye K., Voermans J., Paelinck D., Kos T., Maertens G., Schellekens H., Murray K. 1994; Longitudinal analysis of hepatitis C virus infection and genetic drift of the hypervariable region. Journal of Infectious Diseases 169:1226–1235
     [Google Scholar]
  41. Weiner A. J., Brauer M. J., Rosenblatt J., Richman K. H., Tung J., Crawford K., Bonino F., Saracco G., Choo Q.-L., Houghton M., Han J. H. 1991; Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and NS1 proteins and the pestivirus envelope glycoproteins. Virology 180:842–848
     [Google Scholar]
  42. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A., Brunetto M., Bar P. J., Miyamuta T., McHutchinson J., Houghton M. 1992; Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infection. Proceedings of the National Academy of Sciences, USA 89:3468–3472
     [Google Scholar]
  43. Weiner A., Erickson A. L., Kansopon J., Crawford K., Muchmore E., Hughes A. L., Houghton M., Walker C. M. 1995; Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences, USA 92:2755–2759
     [Google Scholar]
  44. Yoshioka K., Aiyama T., Okumura A., Takayanagi M., Iwata K., Ishikawa T., Nagai Y., Kakumu S. 1997; Humoral immune response to the hypervariable region of hepatitis C virus differs between genotypes 1b and 2a. Journal of Infectious Diseases 175:505–510
     [Google Scholar]
  45. Yuki N., Hayashi N., Moribe T., Matsushita Y., Tabata T., Inoue T., Kanazawa Y., Ohkawa K., Kasahara A., Fusamoto H., Kamada T. 1997; Relation of disease activity during chronic hepatitis C infection to complexity of hypervariable region 1 quasispecies. Hepatology 25:439–444
     [Google Scholar]
  46. Zibert A., Schreiber E., Roggendorf M. 1995; Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment. Virology 208:653–661
     [Google Scholar]
  47. Zibert A., Kraas W., Meisel H., Jung G., Roggendorf M. 1997; Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus. Journal of Virology 71:4123–4127
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-2-317
Loading
Ontogeny of hepatitis C virus (HCV) hypervariable region 1 (HVR1) heterogeneity and HVR1 antibody responses over a 3 year period in a patient infected with HCV type 2b
J. Gen. Virol. 80, 317 (1999); https://doi.org/10.1099/0022-1317-80-2-317
/content/journal/jgv/10.1099/0022-1317-80-2-317
/content/journal/jgv/10.1099/0022-1317-80-2-317
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error